Microcarrier Market Size, Share & Trends Analysis By Product, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Global microcarrier market is projected to be worth USD 4.07 billion by 2030
According to SPER Market Research, the microcarrier market is estimated to reach USD 4.07 billion by 2030 with a CAGR of 10.2%. There is higher risk of virus outbreak due to climate change and increasing population. This creates opportunities for microcarrier market to grow.
Impact of COVID-19 on the Microcarrier Market
The outburst of COVID-19 infections at global level forced the governments to declare nation-wide lockdowns and norms for social distancing. The small and large players in pharmaceuticals focused on developing vaccines and other therapies against SARS-CoV-2 Research and development quickly escalated and were largely unaffected by the lockdowns and restrictions due to the support and funding. Demand for cell culture products also increased including microcarrier products. Cell culture is an important part of vaccine development which has increased the demand for microcarrier products.
Scope of the report:
Market size available for years 2019-2030
Base year considered 2021
Forecast period 2022-2030
Segments covered By Product, By Application, By End User
Geographies covered North America, Europe, APAC, Latin America and the Middle East & Africa
Companies Covered BD, CESCO Bioengineering, ChemoMetec, Corning, Danaher Corporation, Eppendorf AG, Fischer Scientific, HiMedia Laboratories, Merck, Sartorius AG
Driver: Increasing demand for cell-based vaccines
Rapidly increasing population, close proximity between animals and humans have created favorable conditions for virus outbreaks. This increases the demand for cell culture to develop cell-based vaccines. There is a higher risk of a pandemic in future creating urgent need for cell-based vaccines due to higher efficiency, large production capacity and shorter lead time. Clinical studies have also suggested cell-based vaccines as safe and effective for use in humans.
Restraints: High research and development cost
R&D in cell biology is an expensive process involving reagents and equipment of higher quality and precision in results. The high-quality standards issued by regulatory authorities increases the cost of the research. Thus, small players and academic institutes cannot afford to carry out this research which restraints the growth of this market in the forecast period.
Opportunity: Rising demand for monoclonal antibody
Monoclonal antibodies are increasing in demand for targeted delivery for cancer treatments and immune diseases. The monoclonal antibodies are administered at higher doses thus, production is also required equally high. This creates growth opportunities for microcarriers.
Microcarrier Market by Product:
Based on product, market has been segmented into Consumables (Media [Sera/Serum-based Media, Serum-free Media, Other Media], Reagents, Microcarriers [Collagen-coated Microcarriers, Cationic Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers, Other Microcarriers]), Equipment (Bioreactors [Single-use Bioreactors, Stainless-steel Bioreactors], Culture Vessels, Filtration and Separation Equipment, Cell Counters, Other Equipment)
Microcarrier Market by Application:
Based on application, the market is segmented into Biopharmaceutical Production (Vaccine Production, Therapeutic Protein Production), Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications
Microcarrier Market by End User:
Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes, Cell Banks
Pharmaceutical & Biotechnological companies have the largest share of this market by end user due to changing regulatory scenarios of cell-based vaccines and rising awareness for cell-based vaccines for its benefits.
Microcarrier Market by Region:
North America owns the largest share of this market owing to increasing R&D activities, technological advancements, increasing investments and funding in cell-based research and presence of leading players of this market.
According to SPER Market Research, the microcarrier market is estimated to reach USD 4.07 billion by 2030 with a CAGR of 10.2%. There is higher risk of virus outbreak due to climate change and increasing population. This creates opportunities for microcarrier market to grow.
Impact of COVID-19 on the Microcarrier Market
The outburst of COVID-19 infections at global level forced the governments to declare nation-wide lockdowns and norms for social distancing. The small and large players in pharmaceuticals focused on developing vaccines and other therapies against SARS-CoV-2 Research and development quickly escalated and were largely unaffected by the lockdowns and restrictions due to the support and funding. Demand for cell culture products also increased including microcarrier products. Cell culture is an important part of vaccine development which has increased the demand for microcarrier products.
Scope of the report:
Market size available for years 2019-2030
Base year considered 2021
Forecast period 2022-2030
Segments covered By Product, By Application, By End User
Geographies covered North America, Europe, APAC, Latin America and the Middle East & Africa
Companies Covered BD, CESCO Bioengineering, ChemoMetec, Corning, Danaher Corporation, Eppendorf AG, Fischer Scientific, HiMedia Laboratories, Merck, Sartorius AG
Driver: Increasing demand for cell-based vaccines
Rapidly increasing population, close proximity between animals and humans have created favorable conditions for virus outbreaks. This increases the demand for cell culture to develop cell-based vaccines. There is a higher risk of a pandemic in future creating urgent need for cell-based vaccines due to higher efficiency, large production capacity and shorter lead time. Clinical studies have also suggested cell-based vaccines as safe and effective for use in humans.
Restraints: High research and development cost
R&D in cell biology is an expensive process involving reagents and equipment of higher quality and precision in results. The high-quality standards issued by regulatory authorities increases the cost of the research. Thus, small players and academic institutes cannot afford to carry out this research which restraints the growth of this market in the forecast period.
Opportunity: Rising demand for monoclonal antibody
Monoclonal antibodies are increasing in demand for targeted delivery for cancer treatments and immune diseases. The monoclonal antibodies are administered at higher doses thus, production is also required equally high. This creates growth opportunities for microcarriers.
Microcarrier Market by Product:
Based on product, market has been segmented into Consumables (Media [Sera/Serum-based Media, Serum-free Media, Other Media], Reagents, Microcarriers [Collagen-coated Microcarriers, Cationic Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers, Other Microcarriers]), Equipment (Bioreactors [Single-use Bioreactors, Stainless-steel Bioreactors], Culture Vessels, Filtration and Separation Equipment, Cell Counters, Other Equipment)
Microcarrier Market by Application:
Based on application, the market is segmented into Biopharmaceutical Production (Vaccine Production, Therapeutic Protein Production), Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications
Microcarrier Market by End User:
Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes, Cell Banks
Pharmaceutical & Biotechnological companies have the largest share of this market by end user due to changing regulatory scenarios of cell-based vaccines and rising awareness for cell-based vaccines for its benefits.
Microcarrier Market by Region:
North America owns the largest share of this market owing to increasing R&D activities, technological advancements, increasing investments and funding in cell-based research and presence of leading players of this market.
1. INTRODUCTION
1.1. Scope of the report
1.2. Market segment analysis
2. RESEARCH METHODOLOGY
2.1. Research data source
2.1.1. Secondary data
2.1.2. Primary data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impact of the Microcarrier Market
5. MARKET VARIABLES AND OUTLOOK
5.1. SWOT analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL analysis
5.2.1. Political landscape
5.2.2. Economic landscape
5.2.3. Social landscape
5.2.4. Technological landscape
5.2.5. Environmental landscape
5.2.6. Legal landscape
5.3. PORTER’S five forces analysis
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of Buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat map analysis
6. GLOBAL MICROCARRIER MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
6.1. Consumables
6.1.1. Media
6.1.1.1. Sera/Serum-based Media
6.1.1.2. Serum-free Media
6.1.1.3. Other Media
6.1.2. Reagents
6.1.3. Microcarriers
6.1.3.1. Collagen-coated Microcarriers
6.1.3.2. Cationic Microcarriers
6.1.3.3. Protein-coated Microcarriers
6.1.3.4. Untreated Microcarriers
6.1.3.5. Other Microcarriers
6.2. Equipment
6.2.1. Bioreactors
6.2.1.1. Single-use Bioreactors
6.2.1.2. Stainless-steel Bioreactors
6.2.2. Culture Vessels
6.2.3. Filtration and Separation Equipment
6.2.4. Cell Counters
6.2.5. Other Equipment
7. GLOBAL MICROCARRIER MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
7.1. Biopharmaceutical Production
7.1.1. Vaccine Production
7.1.2. Therapeutic Protein Production
7.2. Cell and Gene Therapy
7.3. Tissue Engineering and Regenerative Medicine
7.4. Other Applications
8. GLOBAL MICROCARRIER MARKET, BY END USER, 2019-2030 (USD MILLION)
8.1. Pharmaceutical & Biotechnology Companies
8.2. Contract Research Organizations & Contract Manufacturing Organizations
8.3. Academic & Research Institutes
8.4. Cell Banks
9. GLOBAL MICROCARRIER MARKET, BY REGION, 2019-2030 (USD MILLION)
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia-Pacific
9.4. South America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Rest of South America
9.5. Middle East & Africa
9.5.1. Kingdom of Saudi Arabia
9.5.2. United Arab Emirates
9.5.3. Rest of Middle East & Africa
10. COMPANY PROFILES
10.1. BD
10.1.1. Company details
10.1.2. Financial outlook
10.1.3. Product summary
10.1.4. Recent developments
10.2. CESCO Bioengineering
10.2.1. Company details
10.2.2. Financial outlook
10.2.3. Product summary
10.2.4. Recent developments
10.3. ChemoMetec
10.3.1. Company details
10.3.2. Financial outlook
10.3.3. Product summary
10.3.4. Recent developments
10.4. Corning
10.4.1. Company details
10.4.2. Financial outlook
10.4.3. Product summary
10.4.4. Recent developments
10.5. Danaher Corporation
10.5.1. Company details
10.5.2. Financial outlook
10.5.3. Product summary
10.5.4. Recent developments
10.6. Eppendorf AG
10.6.1. Company details
10.6.2. Financial outlook
10.6.3. Product summary
10.6.4. Recent developments
10.7. Fischer Scientific
10.7.1. Company details
10.7.2. Financial outlook
10.7.3. Product summary
10.7.4. Recent developments
10.8. HiMedia Laboratories
10.8.1. Company details
10.8.2. Financial outlook
10.8.3. Product summary
10.8.4. Recent developments
10.9. Merck
10.9.1. Company details
10.9.2. Financial outlook
10.9.3. Product summary
10.9.4. Recent developments
10.10. Sartorius AG
10.10.1. Company details
10.10.2. Financial outlook
10.10.3. Product summary
10.10.4. Recent developments
1.1. Scope of the report
1.2. Market segment analysis
2. RESEARCH METHODOLOGY
2.1. Research data source
2.1.1. Secondary data
2.1.2. Primary data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impact of the Microcarrier Market
5. MARKET VARIABLES AND OUTLOOK
5.1. SWOT analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL analysis
5.2.1. Political landscape
5.2.2. Economic landscape
5.2.3. Social landscape
5.2.4. Technological landscape
5.2.5. Environmental landscape
5.2.6. Legal landscape
5.3. PORTER’S five forces analysis
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of Buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat map analysis
6. GLOBAL MICROCARRIER MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
6.1. Consumables
6.1.1. Media
6.1.1.1. Sera/Serum-based Media
6.1.1.2. Serum-free Media
6.1.1.3. Other Media
6.1.2. Reagents
6.1.3. Microcarriers
6.1.3.1. Collagen-coated Microcarriers
6.1.3.2. Cationic Microcarriers
6.1.3.3. Protein-coated Microcarriers
6.1.3.4. Untreated Microcarriers
6.1.3.5. Other Microcarriers
6.2. Equipment
6.2.1. Bioreactors
6.2.1.1. Single-use Bioreactors
6.2.1.2. Stainless-steel Bioreactors
6.2.2. Culture Vessels
6.2.3. Filtration and Separation Equipment
6.2.4. Cell Counters
6.2.5. Other Equipment
7. GLOBAL MICROCARRIER MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
7.1. Biopharmaceutical Production
7.1.1. Vaccine Production
7.1.2. Therapeutic Protein Production
7.2. Cell and Gene Therapy
7.3. Tissue Engineering and Regenerative Medicine
7.4. Other Applications
8. GLOBAL MICROCARRIER MARKET, BY END USER, 2019-2030 (USD MILLION)
8.1. Pharmaceutical & Biotechnology Companies
8.2. Contract Research Organizations & Contract Manufacturing Organizations
8.3. Academic & Research Institutes
8.4. Cell Banks
9. GLOBAL MICROCARRIER MARKET, BY REGION, 2019-2030 (USD MILLION)
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia-Pacific
9.4. South America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Rest of South America
9.5. Middle East & Africa
9.5.1. Kingdom of Saudi Arabia
9.5.2. United Arab Emirates
9.5.3. Rest of Middle East & Africa
10. COMPANY PROFILES
10.1. BD
10.1.1. Company details
10.1.2. Financial outlook
10.1.3. Product summary
10.1.4. Recent developments
10.2. CESCO Bioengineering
10.2.1. Company details
10.2.2. Financial outlook
10.2.3. Product summary
10.2.4. Recent developments
10.3. ChemoMetec
10.3.1. Company details
10.3.2. Financial outlook
10.3.3. Product summary
10.3.4. Recent developments
10.4. Corning
10.4.1. Company details
10.4.2. Financial outlook
10.4.3. Product summary
10.4.4. Recent developments
10.5. Danaher Corporation
10.5.1. Company details
10.5.2. Financial outlook
10.5.3. Product summary
10.5.4. Recent developments
10.6. Eppendorf AG
10.6.1. Company details
10.6.2. Financial outlook
10.6.3. Product summary
10.6.4. Recent developments
10.7. Fischer Scientific
10.7.1. Company details
10.7.2. Financial outlook
10.7.3. Product summary
10.7.4. Recent developments
10.8. HiMedia Laboratories
10.8.1. Company details
10.8.2. Financial outlook
10.8.3. Product summary
10.8.4. Recent developments
10.9. Merck
10.9.1. Company details
10.9.2. Financial outlook
10.9.3. Product summary
10.9.4. Recent developments
10.10. Sartorius AG
10.10.1. Company details
10.10.2. Financial outlook
10.10.3. Product summary
10.10.4. Recent developments
